AustralianSuper Pty Ltd Trims Position in Solventum Co. (NYSE:SOLV)

AustralianSuper Pty Ltd lessened its position in Solventum Co. (NYSE:SOLV - Free Report) by 8.9% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 124,573 shares of the company's stock after selling 12,143 shares during the period. AustralianSuper Pty Ltd owned approximately 0.07% of Solventum worth $8,229,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. New York State Teachers Retirement System lifted its position in Solventum by 4.0% in the fourth quarter. New York State Teachers Retirement System now owns 124,699 shares of the company's stock valued at $8,238,000 after purchasing an additional 4,819 shares during the period. Compagnie Lombard Odier SCmA lifted its holdings in shares of Solventum by 98.5% in the 4th quarter. Compagnie Lombard Odier SCmA now owns 2,015 shares of the company's stock valued at $133,000 after buying an additional 1,000 shares during the period. Vontobel Holding Ltd. boosted its stake in shares of Solventum by 11.6% in the fourth quarter. Vontobel Holding Ltd. now owns 5,292 shares of the company's stock valued at $350,000 after buying an additional 552 shares in the last quarter. Asset Management One Co. Ltd. grew its holdings in Solventum by 2.4% during the fourth quarter. Asset Management One Co. Ltd. now owns 54,877 shares of the company's stock worth $3,662,000 after acquiring an additional 1,280 shares during the period. Finally, PrairieView Partners LLC lifted its holdings in Solventum by 3.6% in the fourth quarter. PrairieView Partners LLC now owns 9,530 shares of the company's stock valued at $629,000 after acquiring an additional 334 shares during the period.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the stock. Mizuho assumed coverage on shares of Solventum in a research note on Wednesday, December 4th. They set a "neutral" rating and a $70.00 price target on the stock. Morgan Stanley increased their target price on shares of Solventum from $60.00 to $73.00 and gave the company an "equal weight" rating in a report on Monday, November 11th. Finally, Piper Sandler boosted their price target on Solventum from $71.00 to $75.00 and gave the stock a "neutral" rating in a research note on Friday, November 8th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average target price of $68.29.

Solventum Trading Down 0.5 %

Shares of SOLV traded down $0.38 during mid-day trading on Wednesday, reaching $73.97. 610,722 shares of the company's stock were exchanged, compared to its average volume of 910,654. Solventum Co. has a 52-week low of $47.16 and a 52-week high of $96.05. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. The company has a 50-day simple moving average of $70.91 and a two-hundred day simple moving average of $68.88.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.